Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Brombin

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2014
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivoDaniela Cesana, Marco Ranzani, Monica Volpin, et al.
Tumori|April 19, 2025
18F-FDG PET/CT guided salvage radiotherapy strategies for lymph-nodal relapses in gynecological cancers: SBRT vs ENRTAndrei Fodor, Martina Midulla, Chiara Brombin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2025
Tweaking lentiviral vector design balances efficacy and safety in liver-directed gene therapy for familial hypercholesterolemiaCesare Canepari, Michela Milani, Sara Degl'Innocenti, et al.
Clinical Breast Cancer|December 27, 2021
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer PatientsAndrei Fodor, Chiara Brombin, Paola Mangili, et al.
Cell Reports. Medicine|June 4, 2025
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cellsAnastasia Conti, Kety Giannetti, Federico Midena, et al.
Radiation Oncology (London, England)|August 27, 2025
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRTAndrei Fodor, Laura Giannini, Miriam Torrisi, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2019
Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndromeLucia Sereni, Maria Carmina Castiello, Dario Di Silvestre, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2014
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patientsImmacolata Brigida, Aisha V Sauer, Francesca Ferrua, et al.
Cell Stem Cell|October 7, 2022
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cellsSamuele Ferrari, Aurelien Jacob, Daniela Cesana, et al.
Circulation. Arrhythmia and Electrophysiology|December 19, 2018
Predictive Score for Identifying Survival and Recurrence Risk Profiles in Patients Undergoing Ventricular Tachycardia Ablation: The I-VT ScorePasquale Vergara, Wendy S Tzou, Roderick Tung, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2014
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivoDaniela Cesana, Marco Ranzani, Monica Volpin, et al.
Tumori|April 19, 2025
18F-FDG PET/CT guided salvage radiotherapy strategies for lymph-nodal relapses in gynecological cancers: SBRT vs ENRTAndrei Fodor, Martina Midulla, Chiara Brombin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2025
Tweaking lentiviral vector design balances efficacy and safety in liver-directed gene therapy for familial hypercholesterolemiaCesare Canepari, Michela Milani, Sara Degl'Innocenti, et al.
Clinical Breast Cancer|December 27, 2021
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer PatientsAndrei Fodor, Chiara Brombin, Paola Mangili, et al.
Cell Reports. Medicine|June 4, 2025
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cellsAnastasia Conti, Kety Giannetti, Federico Midena, et al.
Radiation Oncology (London, England)|August 27, 2025
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRTAndrei Fodor, Laura Giannini, Miriam Torrisi, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2019
Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndromeLucia Sereni, Maria Carmina Castiello, Dario Di Silvestre, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2014
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patientsImmacolata Brigida, Aisha V Sauer, Francesca Ferrua, et al.
Cell Stem Cell|October 7, 2022
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cellsSamuele Ferrari, Aurelien Jacob, Daniela Cesana, et al.
Circulation. Arrhythmia and Electrophysiology|December 19, 2018
Predictive Score for Identifying Survival and Recurrence Risk Profiles in Patients Undergoing Ventricular Tachycardia Ablation: The I-VT ScorePasquale Vergara, Wendy S Tzou, Roderick Tung, et al.
Pageof 7